» Articles » PMID: 11044215

Induction of Hyaluronan Metabolism After Mechanical Injury of Human Peritoneal Mesothelial Cells in Vitro

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2000 Oct 24
PMID 11044215
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hyaluronan (HA) is an important extracellular matrix component that is involved in cell movement and tissue repair. In vertebrates, HA synthase genes (HAS 1, HAS 2, and HAS 3) that control the synthesis of HA have been identified. In this article, we investigated HA synthesis in the response of human peritoneal mesothelial cells (HPMCs) to injury.

Methods: The expression of HAS 1, HAS 2, and HAS 3 mRNA and the synthesis of [(3)H]-labeled HA were examined in an in vitro model of peritoneal mesothelial cell damage. The staining for uridine diphosphoglucose dehydrogenase, a key enzyme in the synthesis of HA, and biotinylated HA-binding protein was used to determine the cellular location of HA synthesis and its site of deposition.

Results: Growth-arrested human HPMCs expressed low levels of mRNA for HAS 2 and HAS 3 but not HAS 1. Following injury to the monolayer, HAS 2 was up-regulated by 6 hours, reaching maximal expression between 12 and 24 hours. In contrast, the expression of HAS 3 was down-regulated. During the same time period, synthesis of HA was increased in the injured monolayer. This synthetic activity appeared to be restricted to cells at the edge of the wound and to cells entering the wound. In a separate series of experiments, the addition of HA to the injured monolayer at a concentration range found in peritoneal fluid (50 to 3300 ng/mL) increased the migration of cells into the wound in a dose-dependent manner.

Conclusions: These studies provide evidence that HA is an important component of peritoneal mesothelial cell migration. The results also suggest that in this process, there is differential regulation of HAS gene expression and that the synthesis of HA is limited to cells located at the leading edge of the wound.

Citing Articles

Aggrecan and Hyaluronan: The Infamous Cartilage Polyelectrolytes - Then and Now.

Plaas A, Moran M, Sandy J, Hascall V Adv Exp Med Biol. 2023; 1402:3-29.

PMID: 37052843 DOI: 10.1007/978-3-031-25588-5_1.


Endogenously-Produced Hyaluronan and Its Potential to Regulate the Development of Peritoneal Adhesions.

Kocurkova A, Nesporova K, Sandanusova M, Kerberova M, Lehka K, Velebny V Biomolecules. 2022; 12(1).

PMID: 35053193 PMC: 8773905. DOI: 10.3390/biom12010045.


Tissue-specific Fixation Methods Are Required for Optimal In Situ Visualization of Hyaluronan in the Ovary, Kidney, and Liver.

Rowley J, Rubenstein G, Manuel S, Johnson N, Surgnier J, Kapitsinou P J Histochem Cytochem. 2019; 68(1):75-91.

PMID: 31714169 PMC: 6931168. DOI: 10.1369/0022155419884879.


Serum levels of the endothelial glycocalyx constituents and the early failure of forearm autologous arteriovenous fistulas in end-stage renal disease patients: a prospective cohort study.

Kong X, Du J, Su H, Chen Q, Tang L, Zhang L Int Urol Nephrol. 2019; 52(1):169-177.

PMID: 31667689 DOI: 10.1007/s11255-019-02317-9.


Preparation of Gelatin and Gelatin/Hyaluronic Acid Cryogel Scaffolds for the 3D Culture of Mesothelial Cells and Mesothelium Tissue Regeneration.

Kao H, Kuo C, Chen K, Chen J Int J Mol Sci. 2019; 20(18).

PMID: 31547444 PMC: 6770111. DOI: 10.3390/ijms20184527.